RNA-focused biotech startup Skyhawk Therapeutics has raised $133 million as a pre-IPO “cushion” as it prepares a slew of drugs for clinical development.

Boston Biz Journal https://www.bizjournals.com/boston/news/2021/09/15/skyhawk-therapeutics-133m-investment-ipo-plans.html?ana=RSS&s=article_search